• The LA Deal Sheet
• Miami Hotelier: Numbers Won't Bounce Back Until '2023 At The Earliest'
• This Week's Dallas-Fort Worth Deal Sheet
• PHOTOS: Construction Continues In D.C. During Stay-At-Home Order
• Blackstone’s Coronavirus Playbook
• A Look Inside The Most Sustainable Office Tower In London
• Unpacking the Federal Stimulus Package With Real Estate Roundtable CEO Jeff DeBoer
• Leading By Example With Facebook Global Business Group VP Katherine Shappley
• New York's Economic Recovery Depends On Federal Funding That Might Not Arrive
• Beyond The Bio: 16 Questions With Cushman & Wakefield Logistics And Industrial Lead Tray Anderson
• New Government Rules Will Force Landlords To Negotiate With Tenants
• Ritz-Carlton, Hotel Indigo Among Ashford Hospitality Atlanta Hotels To Get PPP Loans
• JCPenney Bankruptcy? Analysts Say It's Valuable Enough To Survive
• Tenants Returning To Boston Offices Will Find A Strange New World
• Conservatism During The Expansion Is Paying Off For REITs So Far
• It Will Be A 'Long, Slow Climb' Out Of Recession For Downtown Seattle
• Tysons Office Sale Closes At $6M Discount From Contract Price
• Historic Paradise Theatre Finishes Reboot
• As Some States Lift Restrictions, CRE Gets Ready To Go Back To The Office
• Upmarket Movie Theater Chain CMX Files For Chapter 11, Slams Landlords, Studios
• Jefferson Park Density To Increase Nearly 20%
• My New Normal: SVN Desert Commercial Advisors Director Of Marketing, PR And Administration Melissa Swader
• In A Post-Pandemic Future, Coworking May Be Multifamily's Newest Amenity
• Silverstein CEO Marty Burger: Don’t Expect Office Demand To Go Down, Despite Decrease In Leasing Activity
• Grocers, Startups And Wholesalers Scramble To Meet Demand For Online Groceries
• Developers Hope Affordable Housing Financing Gets Rethought
• Tough Conversations: How Landlords Are Negotiating With Their Tenants Over Unpaid Rent
• What Will Re-Entry Look Like? 300 HR Execs' Answers
• How A Downturn Can Make CRE’s Talent Shortage Even Worse
• EXCLUSIVE: CalPERS, GI Partners Ink $81M Buy Of Biotech HQ